Assessment of Hepatic Fibrosis With Magnetic Resonance Elastography
Refers to article:
Stiffness and Impedance: The New Liver Biomarkers
Raza Malik, Nezam Afdhal
Clinical Gastroenterology and Hepatology
October 2007 (Vol. 5, Issue 10, Pages 1144-1146) Full Text |
Full-Text PDF (180 KB)
Background & Aims: Accurate detection of hepatic fibrosis is crucial for assessing prognosis and candidacy for treatment in patients with chronic liver disease. Magnetic resonance (MR) elastography, a technique for quantitatively assessing the mechanical properties of soft tissues, has been shown previously to have potential for noninvasively detecting liver fibrosis. The goal of this work was to obtain preliminary estimates of the sensitivity and specificity of the technique in diagnosing liver fibrosis, and to assess its potential for identifying patients who potentially can avoid a biopsy procedure. Methods: MR elastography was performed in 35 normal volunteers and 50 patients with chronic liver disease. MR imaging measurements of hepatic fat to water ratios were obtained to assess the potential for fat infiltration to affect stiffness-based detection of fibrosis. Results: Liver stiffness increased systematically with fibrosis stage. Receiver operating curve analysis showed that, with a shear stiffness cut-off value of 2.93 kilopascals, the predicted sensitivity and specificity for detecting all grades of liver fibrosis is 98% and 99%, respectively. Receiver operating curve analysis also provided evidence that MR elastography can discriminate between patients with moderate and severe fibrosis (grades 2–4) and those with mild fibrosis (sensitivity, 86%; specificity, 85%). Hepatic stiffness does not appear to be influenced by the degree of steatosis. Conclusions: MR elastography is a safe, noninvasive technique with excellent diagnostic accuracy for assessing hepatic fibrosis. Based on the high negative predictive value of MR elastography, an initial clinical application may be to triage patients who are under consideration for biopsy examination to assess possible hepatic fibrosis.
⁎Department of Radiology, Mayo Clinic College of Medicine, Rochester, Minnesota
‡Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota
Address requests for reprints to: Richard L. Ehman, Department of Radiology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota 55905; Fax: (507) 284-9778.
Supported by National Institutes of Health grant EB001981. P.J.R. and R.L.E. and their institution hold patents related to this technology and have a potential financial interest in this research.